How much profit has Pharmacielo made this year?
Pharmacielo has made 28.36 M CAD this year.
Pharmacielo Net Income 2024
Pharmacielo Net Income
28.36 M CAD
Ticker
PCLO.V
ISIN
CA71716K1012
WKN
A2PCAX
In 2024, Pharmacielo's profit amounted to 28.36 M CAD, a -274.02% increase from the -16.3 M CAD profit recorded in the previous year.
The Pharmacielo Net Income history
| YEAR | NET INCOME (undefined CAD) |
|---|---|
| 2025e | 39.49 |
| 2024e | 28.36 |
| 2023 | -16.3 |
| 2022 | -14.52 |
| 2021 | -26.63 |
| 2020 | -43.76 |
| 2019 | -34.67 |
| 2018 | -0.14 |
Pharmacielo Revenue, EBIT, Net Income CA71716K1012 · A2PCAX
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Pharmacielo, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Pharmacielo from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Pharmacielo’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Pharmacielo. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Pharmacielo’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Pharmacielo’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Pharmacielo’s growth potential.
Pharmacielo Revenue, EBIT and net profit per share
| Date | Pharmacielo Revenue | Pharmacielo EBIT | Pharmacielo Net Income |
|---|---|---|---|
| 2025e | 296.23 M undefined | 42.87 M undefined | 39.49 M undefined |
| 2024e | 118.49 M undefined | 29.12 M undefined | 28.36 M undefined |
| 2023 | 1.54 M undefined | -10.56 M undefined | -16.3 M undefined |
| 2022 | 5.31 M undefined | -10.53 M undefined | -14.52 M undefined |
| 2021 | 1.95 M undefined | -23.96 M undefined | -26.63 M undefined |
| 2020 | 2.65 M undefined | -41.8 M undefined | -43.76 M undefined |
| 2019 | 786,900 undefined | -32.56 M undefined | -34.67 M undefined |
| 2018 | 0 undefined | -144,400 undefined | -144,400 undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2018 | 0 CAD | -144,400 CAD | -144,400 CAD |
| 2019 | 786,900 CAD | -32.56 M CAD | -34.67 M CAD |
| 2020 | 2.65 M CAD | -41.8 M CAD | -43.76 M CAD |
| 2021 | 1.95 M CAD | -23.96 M CAD | -26.63 M CAD |
| 2022 | 5.31 M CAD | -10.53 M CAD | -14.52 M CAD |
| 2023 | 1.54 M CAD | -10.56 M CAD | -16.3 M CAD |
| 2024e | 118.49 M CAD | 29.12 M CAD | 28.36 M CAD |
| 2025e | 296.23 M CAD | 42.87 M CAD | 39.49 M CAD |
Pharmacielo stock margins CA71716K1012 · A2PCAX
The Pharmacielo margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Pharmacielo. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Pharmacielo.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Pharmacielo's sales revenue. A higher gross margin percentage indicates that the Pharmacielo retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Pharmacielo's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Pharmacielo's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Pharmacielo's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Pharmacielo. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Pharmacielo's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Pharmacielo Margin History
| Pharmacielo Gross margin | Pharmacielo Profit margin | Pharmacielo EBIT margin | Pharmacielo Profit margin |
|---|---|---|---|
| 2025e | -122.1 % | 14.47 % | 13.33 % |
| 2024e | -122.1 % | 24.57 % | 23.93 % |
| 2023 | -122.1 % | -684.69 % | -1,057.09 % |
| 2022 | 29.93 % | -198.3 % | -273.45 % |
| 2021 | -158 % | -1,231.8 % | -1,369.14 % |
| 2020 | -189.76 % | -1,574.89 % | -1,648.72 % |
| 2019 | -14.51 % | -4,137.83 % | -4,405.56 % |
| 2018 | -122.1 % | 0 % | 0 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2018 | -122.1 % | 0 % | 0 % |
| 2019 | -14.51 % | -4,137.83 % | -4,405.56 % |
| 2020 | -189.76 % | -1,574.89 % | -1,648.72 % |
| 2021 | -158 % | -1,231.8 % | -1,369.14 % |
| 2022 | 29.93 % | -198.3 % | -273.45 % |
| 2023 | -122.1 % | -684.69 % | -1,057.09 % |
| 2024e | -122.1 % | 24.57 % | 23.93 % |
| 2025e | -122.1 % | 14.47 % | 13.33 % |
Pharmacielo Aktienanalyse
What does Pharmacielo do?
Pharmacielo Ltd is a company specializing in the production of medical cannabis products. The company is based in Canada, but its production facilities are located in Colombia, one of the most important cultivation areas for cannabis worldwide. The company was founded in 2014 by individuals with experience in commercial cultivation of crops. Its goal is to establish a safe and efficient production of medical cannabis in Colombia to ensure high-quality and affordable supply for patients worldwide. Pharmacielo Ltd's business model is based on the production and delivery of medical cannabis products to customers worldwide. The company produces cannabis flowers, extracts, and oils that are used to treat various medical conditions such as cancer, chronic pain, and neurological disorders. Pharmacielo Ltd works closely with the Colombian government to regulate and standardize the cultivation of medical cannabis to ensure high quality and purity of its products. The company has already received various certifications and approvals confirming the quality and safety of its products. Pharmacielo Ltd is divided into different divisions specializing in production and logistics. The "Production" division is responsible for the cultivation and harvesting of cannabis. Pharmacielo Ltd collaborates with various partners to ensure a large production capacity. The "Extraction" division is responsible for the production of medical cannabis extracts and oils. The dried cannabis flowers are dissolved in a liquid and then extracted to isolate the desired components. The "Logistics" division is responsible for the delivery of products to customers worldwide. The company works with various shipping service providers to ensure fast and reliable delivery of its products. Pharmacielo Ltd offers a wide range of products made from medical cannabis, including cannabis flowers in different varieties and sizes that can be selected based on individual needs. Additionally, products such as oils, extracts, and capsules are offered, which have a higher concentration of cannabinoids and are therefore particularly suitable for the treatment of serious illnesses such as cancer or epilepsy. Overall, Pharmacielo Ltd has become a leading company in the production and delivery of medical cannabis in recent years. The company works closely with the government and other companies to ensure a safe and reliable supply for patients worldwide. With its wide range of products and innovative production technology, Pharmacielo Ltd is well positioned to continue growing and meeting the needs of customers in the future. Pharmacielo ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Pharmacielo's Profit Margins
The profit margins of Pharmacielo represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Pharmacielo's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Pharmacielo's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Pharmacielo's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Pharmacielo’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Pharmacielo stock
How has the profit developed compared to last year?
The profit has increased by -274.02% compared to last year fallen
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Pharmacielo publish its earnings?
Pharmacielo publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Pharmacielo?
The profits of Pharmacielo are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Pharmacielo?
You can learn more about the earnings of Pharmacielo by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Pharmacielo pay?
Over the past 12 months, Pharmacielo paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Pharmacielo is expected to pay a dividend of 0 CAD.
What is the dividend yield of Pharmacielo?
The current dividend yield of Pharmacielo is .
When does Pharmacielo pay dividends?
Pharmacielo pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Pharmacielo?
Pharmacielo paid dividends every year for the past 0 years.
What is the dividend of Pharmacielo?
For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Pharmacielo located?
Pharmacielo is assigned to the 'Health' sector.
Wann musste ich die Aktien von Pharmacielo kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Pharmacielo from 9/20/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 9/20/2024.
When did Pharmacielo pay the last dividend?
The last dividend was paid out on 9/20/2024.
What was the dividend of Pharmacielo in the year 2023?
In the year 2023, Pharmacielo distributed 0 CAD as dividends.
In which currency does Pharmacielo pay out the dividend?
The dividends of Pharmacielo are distributed in CAD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Pharmacielo
Our stock analysis for Pharmacielo Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pharmacielo Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
